Trials / Unknown
UnknownNCT02854696
Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
Health Economic Analysis of Islet Cell Transplantation for Patients With Severe Forms of Brittle Type 1 Diabetes
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The main goal is to perform a cost-utility analysis to compare islet cell transplantation versus best medical treatment (defined as Sensor augmented pump therapy) for patients with brittle type1 diabetes.
Detailed description
The main goal is to perform a cost-utility analysis to compare islet cell transplantation versus best medical treatment (defined as Sensor augmented insulin pump therapy) for patients with brittle type1 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Islet graft | Patients will be transplanted with pancreatic islet cells |
| DRUG | best medical care | Patients will continue their insulin treatment |
Timeline
- Start date
- 2016-07-07
- Primary completion
- 2023-05-01
- Completion
- 2023-12-01
- First posted
- 2016-08-03
- Last updated
- 2022-06-24
Locations
11 sites across 2 countries: France, Switzerland
Source: ClinicalTrials.gov record NCT02854696. Inclusion in this directory is not an endorsement.